ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Respiratory Distress Syndrome Market Insights, Forecast to 2030
Published Date: July 2024
|
Report Code: QYRE-Auto-30X5534
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global Respiratory Distress Syndrome Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Respiratory Distress Syndrome Market Insights, Forecast to 2030

Code: QYRE-Auto-30X5534
Report
July 2024
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Chiesi Farmaceutici
CR Double-Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen

Respiratory Distress Syndrome Market Size

The global Respiratory Distress Syndrome market is projected to grow from US$ 400.2 million in 2024 to US$ 551.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.5% during the forecast period.

Respiratory Distress Syndrome Market

Respiratory Distress Syndrome Market

Respiratory distress syndrome is caused by pulmonary surfactant deficiency in the lungs of neonates, most commonly in those born at < 37 weeks’ gestation. Risk increases with degree of prematurity. Symptoms and signs include grunting respirations, use of accessory muscles, and nasal flaring appearing soon after birth. Diagnosis is clinical; prenatal risk can be assessed with tests of fetal lung maturity. Treatment is surfactant therapy and supportive care. Treatment for RDS usually begins as soon as a newborn is born, sometimes in the delivery room. Treatments for RDS include surfactant replacement therapy, breathing support from a ventilator or nasal continuous positive airway pressure (NCPAP) machine, or other supportive treatments.
Market Analysis and Insights: Global Respiratory Distress Syndrome Market
North America is the largest consumption place, with a consumption market share nearly 33% . Following North America, China is the second largest consumption place with the consumption market share of 26%.The key manufacturers are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen etc. Top 3 companies occupied about 85% market share.
Report Covers:
This report presents an overview of global market for Respiratory Distress Syndrome market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Respiratory Distress Syndrome, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Respiratory Distress Syndrome, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Respiratory Distress Syndrome revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Respiratory Distress Syndrome market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Respiratory Distress Syndrome revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Respiratory Distress Syndrome Market Report

Report Metric Details
Report Name Respiratory Distress Syndrome Market
Accounted market size in 2024 US$ 400.2 million
Forecasted market size in 2030 US$ 551.9 million
CAGR 5.5
Base Year 2024
Forecasted years 2024 - 2030
Segment by Type
  • Poractant Alfa
  • Beractant
  • Calfactant
  • Others
Segment by Application
  • Very Preterm Infants
  • Moderate to Late Preterm Infants
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Respiratory Distress Syndrome in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Respiratory Distress Syndrome companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Respiratory Distress Syndrome revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Respiratory Distress Syndrome Market growing?

Ans: The Respiratory Distress Syndrome Market witnessing a CAGR of 5.5 during the forecast period 2024-2030.

What is the Respiratory Distress Syndrome Market size in 2030?

Ans: The Respiratory Distress Syndrome Market size in 2030 will be US$ 551.9 million.

What is the Respiratory Distress Syndrome Market share by region?

Ans: North America is the largest consumption place, with a consumption market share nearly 33% .

What is the market share of major companies in Respiratory Distress Syndrome Market?

Ans: Top 3 companies occupied about 85% market share.

Who are the main players in the Respiratory Distress Syndrome Market report?

Ans: The main players in the Respiratory Distress Syndrome Market are Chiesi Farmaceutici, CR-Double Crane, ONY Biotech, AbbVie, Yuhan Corporation, JW Pharmaceuticals, Noargen

What are the Application segmentation covered in the Respiratory Distress Syndrome Market report?

Ans: The Applications covered in the Respiratory Distress Syndrome Market report are Very Preterm Infants, Moderate to Late Preterm Infants, Others

What are the Type segmentation covered in the Respiratory Distress Syndrome Market report?

Ans: The Types covered in the Respiratory Distress Syndrome Market report are Poractant Alfa, Beractant, Calfactant, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Poractant Alfa
1.2.3 Beractant
1.2.4 Calfactant
1.2.5 Others
1.3 Market by Application
1.3.1 Global Respiratory Distress Syndrome Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Very Preterm Infants
1.3.3 Moderate to Late Preterm Infants
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Respiratory Distress Syndrome Market Perspective (2019-2030)
2.2 Global Respiratory Distress Syndrome Growth Trends by Region
2.2.1 Respiratory Distress Syndrome Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Respiratory Distress Syndrome Historic Market Size by Region (2019-2024)
2.2.3 Respiratory Distress Syndrome Forecasted Market Size by Region (2025-2030)
2.3 Respiratory Distress Syndrome Market Dynamics
2.3.1 Respiratory Distress Syndrome Industry Trends
2.3.2 Respiratory Distress Syndrome Market Drivers
2.3.3 Respiratory Distress Syndrome Market Challenges
2.3.4 Respiratory Distress Syndrome Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Respiratory Distress Syndrome by Players
3.1.1 Global Respiratory Distress Syndrome Revenue by Players (2019-2024)
3.1.2 Global Respiratory Distress Syndrome Revenue Market Share by Players (2019-2024)
3.2 Global Respiratory Distress Syndrome Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Respiratory Distress Syndrome, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Respiratory Distress Syndrome Market Concentration Ratio
3.4.1 Global Respiratory Distress Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Respiratory Distress Syndrome Revenue in 2023
3.5 Global Key Players of Respiratory Distress Syndrome Head office and Area Served
3.6 Global Key Players of Respiratory Distress Syndrome, Product and Application
3.7 Global Key Players of Respiratory Distress Syndrome, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Respiratory Distress Syndrome Breakdown Data by Type
4.1 Global Respiratory Distress Syndrome Historic Market Size by Type (2019-2024)
4.2 Global Respiratory Distress Syndrome Forecasted Market Size by Type (2025-2030)
5 Respiratory Distress Syndrome Breakdown Data by Application
5.1 Global Respiratory Distress Syndrome Historic Market Size by Application (2019-2024)
5.2 Global Respiratory Distress Syndrome Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Respiratory Distress Syndrome Market Size (2019-2030)
6.2 North America Respiratory Distress Syndrome Market Size by Type
6.2.1 North America Respiratory Distress Syndrome Market Size by Type (2019-2024)
6.2.2 North America Respiratory Distress Syndrome Market Size by Type (2025-2030)
6.2.3 North America Respiratory Distress Syndrome Market Share by Type (2019-2030)
6.3 North America Respiratory Distress Syndrome Market Size by Application
6.3.1 North America Respiratory Distress Syndrome Market Size by Application (2019-2024)
6.3.2 North America Respiratory Distress Syndrome Market Size by Application (2025-2030)
6.3.3 North America Respiratory Distress Syndrome Market Share by Application (2019-2030)
6.4 North America Respiratory Distress Syndrome Market Size by Country
6.4.1 North America Respiratory Distress Syndrome Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Respiratory Distress Syndrome Market Size by Country (2019-2024)
6.4.3 North America Respiratory Distress Syndrome Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Respiratory Distress Syndrome Market Size (2019-2030)
7.2 Europe Respiratory Distress Syndrome Market Size by Type
7.2.1 Europe Respiratory Distress Syndrome Market Size by Type (2019-2024)
7.2.2 Europe Respiratory Distress Syndrome Market Size by Type (2025-2030)
7.2.3 Europe Respiratory Distress Syndrome Market Share by Type (2019-2030)
7.3 Europe Respiratory Distress Syndrome Market Size by Application
7.3.1 Europe Respiratory Distress Syndrome Market Size by Application (2019-2024)
7.3.2 Europe Respiratory Distress Syndrome Market Size by Application (2025-2030)
7.3.3 Europe Respiratory Distress Syndrome Market Share by Application (2019-2030)
7.4 Europe Respiratory Distress Syndrome Market Size by Country
7.4.1 Europe Respiratory Distress Syndrome Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Respiratory Distress Syndrome Market Size by Country (2019-2024)
7.4.3 Europe Respiratory Distress Syndrome Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Respiratory Distress Syndrome Market Size (2019-2030)
8.2 China Respiratory Distress Syndrome Market Size by Type
8.2.1 China Respiratory Distress Syndrome Market Size by Type (2019-2024)
8.2.2 China Respiratory Distress Syndrome Market Size by Type (2025-2030)
8.2.3 China Respiratory Distress Syndrome Market Share by Type (2019-2030)
8.3 China Respiratory Distress Syndrome Market Size by Application
8.3.1 China Respiratory Distress Syndrome Market Size by Application (2019-2024)
8.3.2 China Respiratory Distress Syndrome Market Size by Application (2025-2030)
8.3.3 China Respiratory Distress Syndrome Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Respiratory Distress Syndrome Market Size (2019-2030)
9.2 Asia Respiratory Distress Syndrome Market Size by Type
9.2.1 Asia Respiratory Distress Syndrome Market Size by Type (2019-2024)
9.2.2 Asia Respiratory Distress Syndrome Market Size by Type (2025-2030)
9.2.3 Asia Respiratory Distress Syndrome Market Share by Type (2019-2030)
9.3 Asia Respiratory Distress Syndrome Market Size by Application
9.3.1 Asia Respiratory Distress Syndrome Market Size by Application (2019-2024)
9.3.2 Asia Respiratory Distress Syndrome Market Size by Application (2025-2030)
9.3.3 Asia Respiratory Distress Syndrome Market Share by Application (2019-2030)
9.4 Asia Respiratory Distress Syndrome Market Size by Region
9.4.1 Asia Respiratory Distress Syndrome Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Respiratory Distress Syndrome Market Size by Region (2019-2024)
9.4.3 Asia Respiratory Distress Syndrome Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Type
10.2.1 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Application
10.3.1 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Country
10.4.1 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Chiesi Farmaceutici
11.1.1 Chiesi Farmaceutici Company Details
11.1.2 Chiesi Farmaceutici Business Overview
11.1.3 Chiesi Farmaceutici Respiratory Distress Syndrome Introduction
11.1.4 Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2019-2024)
11.1.5 Chiesi Farmaceutici Recent Developments
11.2 CR-Double Crane
11.2.1 CR-Double Crane Company Details
11.2.2 CR-Double Crane Business Overview
11.2.3 CR-Double Crane Respiratory Distress Syndrome Introduction
11.2.4 CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2019-2024)
11.2.5 CR-Double Crane Recent Developments
11.3 ONY Biotech
11.3.1 ONY Biotech Company Details
11.3.2 ONY Biotech Business Overview
11.3.3 ONY Biotech Respiratory Distress Syndrome Introduction
11.3.4 ONY Biotech Revenue in Respiratory Distress Syndrome Business (2019-2024)
11.3.5 ONY Biotech Recent Developments
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Respiratory Distress Syndrome Introduction
11.4.4 AbbVie Revenue in Respiratory Distress Syndrome Business (2019-2024)
11.4.5 AbbVie Recent Developments
11.5 Yuhan Corporation
11.5.1 Yuhan Corporation Company Details
11.5.2 Yuhan Corporation Business Overview
11.5.3 Yuhan Corporation Respiratory Distress Syndrome Introduction
11.5.4 Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2019-2024)
11.5.5 Yuhan Corporation Recent Developments
11.6 JW Pharmaceuticals
11.6.1 JW Pharmaceuticals Company Details
11.6.2 JW Pharmaceuticals Business Overview
11.6.3 JW Pharmaceuticals Respiratory Distress Syndrome Introduction
11.6.4 JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2019-2024)
11.6.5 JW Pharmaceuticals Recent Developments
11.7 Noargen
11.7.1 Noargen Company Details
11.7.2 Noargen Business Overview
11.7.3 Noargen Respiratory Distress Syndrome Introduction
11.7.4 Noargen Revenue in Respiratory Distress Syndrome Business (2019-2024)
11.7.5 Noargen Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Chiesi Farmaceutici
CR Double-Crane
ONY Biotech
AbbVie
Yuhan Corporation
JW Pharmaceuticals
Noargen
List of Tables
    Table 1. Global Respiratory Distress Syndrome Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Poractant Alfa
    Table 3. Key Players of Beractant
    Table 4. Key Players of Calfactant
    Table 5. Key Players of Others
    Table 6. Global Respiratory Distress Syndrome Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Respiratory Distress Syndrome Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Respiratory Distress Syndrome Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Respiratory Distress Syndrome Market Share by Region (2019-2024)
    Table 10. Global Respiratory Distress Syndrome Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Respiratory Distress Syndrome Market Share by Region (2025-2030)
    Table 12. Respiratory Distress Syndrome Market Trends
    Table 13. Respiratory Distress Syndrome Market Drivers
    Table 14. Respiratory Distress Syndrome Market Challenges
    Table 15. Respiratory Distress Syndrome Market Restraints
    Table 16. Global Respiratory Distress Syndrome Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Respiratory Distress Syndrome Revenue Share by Players (2019-2024)
    Table 18. Global Top Respiratory Distress Syndrome by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Distress Syndrome as of 2023)
    Table 19. Global Respiratory Distress Syndrome Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Respiratory Distress Syndrome Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Respiratory Distress Syndrome, Headquarters and Area Served
    Table 22. Global Key Players of Respiratory Distress Syndrome, Product and Application
    Table 23. Global Key Players of Respiratory Distress Syndrome, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Respiratory Distress Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Respiratory Distress Syndrome Revenue Market Share by Type (2019-2024)
    Table 27. Global Respiratory Distress Syndrome Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Respiratory Distress Syndrome Revenue Market Share by Type (2025-2030)
    Table 29. Global Respiratory Distress Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Respiratory Distress Syndrome Revenue Share by Application (2019-2024)
    Table 31. Global Respiratory Distress Syndrome Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Respiratory Distress Syndrome Revenue Share by Application (2025-2030)
    Table 33. North America Respiratory Distress Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Respiratory Distress Syndrome Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Respiratory Distress Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Respiratory Distress Syndrome Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Respiratory Distress Syndrome Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Respiratory Distress Syndrome Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Respiratory Distress Syndrome Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Respiratory Distress Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Respiratory Distress Syndrome Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Respiratory Distress Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Respiratory Distress Syndrome Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Respiratory Distress Syndrome Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Respiratory Distress Syndrome Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Respiratory Distress Syndrome Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Respiratory Distress Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Respiratory Distress Syndrome Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Respiratory Distress Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Respiratory Distress Syndrome Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Respiratory Distress Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Respiratory Distress Syndrome Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Respiratory Distress Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Respiratory Distress Syndrome Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Respiratory Distress Syndrome Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Respiratory Distress Syndrome Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Respiratory Distress Syndrome Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Respiratory Distress Syndrome Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Chiesi Farmaceutici Company Details
    Table 66. Chiesi Farmaceutici Business Overview
    Table 67. Chiesi Farmaceutici Respiratory Distress Syndrome Product
    Table 68. Chiesi Farmaceutici Revenue in Respiratory Distress Syndrome Business (2019-2024) & (US$ Million)
    Table 69. Chiesi Farmaceutici Recent Developments
    Table 70. CR-Double Crane Company Details
    Table 71. CR-Double Crane Business Overview
    Table 72. CR-Double Crane Respiratory Distress Syndrome Product
    Table 73. CR-Double Crane Revenue in Respiratory Distress Syndrome Business (2019-2024) & (US$ Million)
    Table 74. CR-Double Crane Recent Developments
    Table 75. ONY Biotech Company Details
    Table 76. ONY Biotech Business Overview
    Table 77. ONY Biotech Respiratory Distress Syndrome Product
    Table 78. ONY Biotech Revenue in Respiratory Distress Syndrome Business (2019-2024) & (US$ Million)
    Table 79. ONY Biotech Recent Developments
    Table 80. AbbVie Company Details
    Table 81. AbbVie Business Overview
    Table 82. AbbVie Respiratory Distress Syndrome Product
    Table 83. AbbVie Revenue in Respiratory Distress Syndrome Business (2019-2024) & (US$ Million)
    Table 84. AbbVie Recent Developments
    Table 85. Yuhan Corporation Company Details
    Table 86. Yuhan Corporation Business Overview
    Table 87. Yuhan Corporation Respiratory Distress Syndrome Product
    Table 88. Yuhan Corporation Revenue in Respiratory Distress Syndrome Business (2019-2024) & (US$ Million)
    Table 89. Yuhan Corporation Recent Developments
    Table 90. JW Pharmaceuticals Company Details
    Table 91. JW Pharmaceuticals Business Overview
    Table 92. JW Pharmaceuticals Respiratory Distress Syndrome Product
    Table 93. JW Pharmaceuticals Revenue in Respiratory Distress Syndrome Business (2019-2024) & (US$ Million)
    Table 94. JW Pharmaceuticals Recent Developments
    Table 95. Noargen Company Details
    Table 96. Noargen Business Overview
    Table 97. Noargen Respiratory Distress Syndrome Product
    Table 98. Noargen Revenue in Respiratory Distress Syndrome Business (2019-2024) & (US$ Million)
    Table 99. Noargen Recent Developments
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Respiratory Distress Syndrome Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Respiratory Distress Syndrome Market Share by Type: 2023 VS 2030
    Figure 3. Poractant Alfa Features
    Figure 4. Beractant Features
    Figure 5. Calfactant Features
    Figure 6. Others Features
    Figure 7. Global Respiratory Distress Syndrome Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Respiratory Distress Syndrome Market Share by Application: 2023 VS 2030
    Figure 9. Very Preterm Infants Case Studies
    Figure 10. Moderate to Late Preterm Infants Case Studies
    Figure 11. Others Case Studies
    Figure 12. Respiratory Distress Syndrome Report Years Considered
    Figure 13. Global Respiratory Distress Syndrome Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 14. Global Respiratory Distress Syndrome Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Respiratory Distress Syndrome Market Share by Region: 2023 VS 2030
    Figure 16. Global Respiratory Distress Syndrome Market Share by Players in 2023
    Figure 17. Global Top Respiratory Distress Syndrome Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Distress Syndrome as of 2023)
    Figure 18. The Top 10 and 5 Players Market Share by Respiratory Distress Syndrome Revenue in 2023
    Figure 19. North America Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 20. North America Respiratory Distress Syndrome Market Share by Type (2019-2030)
    Figure 21. North America Respiratory Distress Syndrome Market Share by Application (2019-2030)
    Figure 22. North America Respiratory Distress Syndrome Market Share by Country (2019-2030)
    Figure 23. United States Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Canada Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Respiratory Distress Syndrome Market Size YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Respiratory Distress Syndrome Market Share by Type (2019-2030)
    Figure 27. Europe Respiratory Distress Syndrome Market Share by Application (2019-2030)
    Figure 28. Europe Respiratory Distress Syndrome Market Share by Country (2019-2030)
    Figure 29. Germany Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. France Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. U.K. Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Italy Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Russia Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Nordic Countries Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. China Respiratory Distress Syndrome Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. China Respiratory Distress Syndrome Market Share by Type (2019-2030)
    Figure 37. China Respiratory Distress Syndrome Market Share by Application (2019-2030)
    Figure 38. Asia Respiratory Distress Syndrome Market Size YoY (2019-2030) & (US$ Million)
    Figure 39. Asia Respiratory Distress Syndrome Market Share by Type (2019-2030)
    Figure 40. Asia Respiratory Distress Syndrome Market Share by Application (2019-2030)
    Figure 41. Asia Respiratory Distress Syndrome Market Share by Region (2019-2030)
    Figure 42. Japan Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. South Korea Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. China Taiwan Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. India Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Australia Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Size YoY (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Share by Type (2019-2030)
    Figure 50. Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Share by Application (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Respiratory Distress Syndrome Market Share by Country (2019-2030)
    Figure 52. Brazil Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Mexico Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Turkey Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Saudi Arabia Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Israel Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. GCC Countries Respiratory Distress Syndrome Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Chiesi Farmaceutici Revenue Growth Rate in Respiratory Distress Syndrome Business (2019-2024)
    Figure 59. CR-Double Crane Revenue Growth Rate in Respiratory Distress Syndrome Business (2019-2024)
    Figure 60. ONY Biotech Revenue Growth Rate in Respiratory Distress Syndrome Business (2019-2024)
    Figure 61. AbbVie Revenue Growth Rate in Respiratory Distress Syndrome Business (2019-2024)
    Figure 62. Yuhan Corporation Revenue Growth Rate in Respiratory Distress Syndrome Business (2019-2024)
    Figure 63. JW Pharmaceuticals Revenue Growth Rate in Respiratory Distress Syndrome Business (2019-2024)
    Figure 64. Noargen Revenue Growth Rate in Respiratory Distress Syndrome Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Anesthesia Airway Management Devices - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-24E13497
Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Respiratory Equipment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-21K1868
Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Severe Acute Respiratory Syndrome Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-13A14107
Sat Oct 05 00:00:00 UTC 2024

Add to Cart

COPD Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-11I13934
Tue Oct 01 00:00:00 UTC 2024

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions